Outcomes evaluation for operative and nonoperative management of the abnormal mammogram

American Journal of Surgery

Volumn 175, Issue 1, 1998, Pages 69-72

  McGreevy, James M ^a   Loftus, Terrence J ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREAST BIOPSY; BREAST CANCER; CONSERVATIVE TREATMENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MAMMOGRAPHY; MASS SCREENING; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TREATMENT OUTCOME;

BIOPSY; BREAST; BREAST NEOPLASMS; DATA INTERPRETATION, STATISTICAL; ESTROGENS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAMMOGRAPHY; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POSTMENOPAUSE; PROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS;

EID: 0031963784     PISSN: 00029610     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9610(97)00226-2     Document Type: Article

References (7)

1. 1. Brenner RJ. Medico legal aspects of breast imaging. Radiol Clin North Am. 1992;30:277-286.
2. 2. Brenner RJ. Follow-up as an alternative to biopsy for probably benign mammographically detected abnormalities. Curr Opin Radiol. 1991;3(4):588-592.
3. 3. Morrow M, Schmidt R, Cregger B, et al. Preoperative evaluation of abnormal mammographic findings to avoid unnecessary breast biopsies. Arch Surg. 1994;129:1091-1096.
4. 4. Homer MJ. Nonpalpable mammographic abnormalities: timing the follow-up studies. AJR. 1981;136:923-926.
5. 5. Huvos AG, Hutter RVP, Berg JW. Significance of axillary macro metastases and micro metastases in mammary cancer. Ann Surg. 1971;173:44-46.
6. 6. Geelhoed GW, Barr HM, Curtis DJ, Olmsted WW. Radiologic recommendation for breast biopsy on screening mammography reports. Am Surg. 1991;57(7):419-424.
7. 7. Spicer DV, Giske U, Parisky YR, et al. Changes in mammographic densities induced by a hormonal contraceptive designed to reduce breast cancer risk. J Natl Cancer Inst. 1994;86:431-436.